2Li Ls.End-Stage renal disease in China.Kidney Int,1995,49:287.
3Haffner SM,D'Agostino R,Mykkanen L.Insulin sensiti vity in subjects with type 2 diabetes.Diabetes Care,1999,22(4):562-568.
4Ford ES,Giles WH,Dietz WH.Prevalence of the metabolic syndrome among US adults:Findings from the Third National Health and Nutrition Examination Survey.JAMA,2002,287(3):356-359.
5Jia WP,Xiang KS,Chen L,et al.Epidemiologic study on metabolic syndrome in mormal and overweight Chinese in Shanghai.Diabetes,2000,49(suppl 1):A184.
6Hoehner CM,Green Lund KJ,Rith-Najarian S,et al.Association of the Insulin Resistance Syndrome and Microalbuminuria among Nondiabetic Native Americans.The Inter-Tribal Heart Project.J Am Soc Nephrol,2002,13(6):1626-1634.
7Zierath JR,Livingston JN,Thome A,et al.Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes:Relation to insulin receptor phosphorylation and intracellular signaling through the insulin receptor substrate-1 pathway.Diabetologia,1998,41(11):1343-1354.
8Boden G.Effects of free fatty acids (FFA) on glucose metabolism:significance for insulin resistance and type 2 diabetes.Exp Clin Endocrinol Diabetes,2003,111(3):121-124.
2[2]Brancati FL,Cusumano AM.Epidemiology and prevention of diabetic nephropathy[J].Curr Opin Nephrol Hypertens,1995;4(3):223-229
3[3]Breyer JA.Diabetic nephropathy in insulin-dependent patients[J].Am J Kindey Dis,1992;20:533-547
4[4]Hostetter TH.Early renal function in diabetes and risk factors for development of diabetic nephropathy.in:Jacobson HR,Striker CE,Klahr S,eds.The principles and practice of nephrology[M].Philadelphia BC Decker,1991:460-462
5[5]Mongensen CE.Microalbuminuria as a predictor of clinical diabetic nephropathy[J].Kidney Int,1987;31(2):673-689
6[6]Viberti GC,Wiseman M.The kidney in diabetes:Significance of early abnormalities[J].Clin Endocrinol Metab,1986;9:85-92
7[7]Nielsen S,Schmitz A,Mogensen CE.Rate of progression of nephropathy in normal and microalbuminurial type Ⅱ diabetic patients.Diabetologia[J],1991;34(suppl 2):A144
8[8]Schmitz A.Microalbuminuria and mortality in non-insulin-depen dent diabetes.In:Mogensen CE,ed.The Kidney and Hypertension in Diabetesc[M].Boston:Martinus Nijhoff Publishing,1988:6570
9[9]Christensen CK,Mogensen CE.The course of incipients nephropathy:studies on albumin excretion and blood pressure[J].Diabetic Med,1985;2:97-102
10[10]Gilbert RE,Tsalamandris C,Bach LA et al.Long-term glycaemic control and the rate of progression of early diabetic kidney disease[J].Kidney Int,1993;44:855-859
5Yang W,Lu J,Weng J. Prevalence of diabetes among men and women in China[J].{H}New England Journal of Medicine,2010,(12):1090-1101.
6Yao Q,Zhang W,Qian J. Peritoneal dialysis in Shanghai[J].{H}Peritoneal Dialysis International,2008,(Suppl 3):S42-S45.
7王海燕.肾脏病学[M]{H}北京:人民卫生出版社,20081426-1429.
8陈以平.肾病的辨证与辨病治疗[M]{H}北京:人民卫生出版社,2003146-147.
9Das SK,Chakrabarti R. Non-insulin dependent diabetes mellitus:present therapies and new drug targets[J].{H}Mini Reviews in Medicinal Chemistry,2005,(11):1019-1034.
10Bostr?mP, WuJ, JedrychowskiMP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis[J]. Nature, 2012, 481(7382):463-468. DOI: 10.1038/nature10777.
